Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Site-Less Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders

NCT07847918 is registered in ClinicalTrials.gov with Scripps Translational Science Institute as lead sponsor.

NCT NCT07847918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07847918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Site-Less Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders
Lead sponsor
Scripps Translational Science Institute
Phase
Phase 2
Overall status
Recruiting
Start date
October 31, 2026
Completion date
October 31, 2032
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

slc6a1